(01)
Evidence
Structured context is built by unifying knowledge from internal records, publications, clinical history, and competitive intelligence - then sharpened with your team's tacit knowledge, expertise, and judgment.
Perceptic connects evidence, data, decisions, and workflows across the drug development lifecycle, so every insight compounds.
The shift
Drug development's hardest problems won't be solved by faster workflows. They'll be solved by decisions that draw on everything an organization knows, made by people with the intuition to see what matters.
Perceptic is the AI connective tissue that makes those decisions possible: we unify evidence, data, and reasoning across teams and tools, so insights from one corner of the organization can shape choices in another. We extend the infrastructure scientists already rely on, add traceable decision workflows, and learn continuously from their work, so the full weight of the organization's knowledge stands behind every call.
Platform
Perceptic provides the mission control for the full drug development lifecycle. Our platform unifies asset scouting, scientific evaluation, and clinical data foundations on a shared transparent intelligence layer: one system where every insight compounds and every decision draws on the full picture.

(01)
Structured context is built by unifying knowledge from internal records, publications, clinical history, and competitive intelligence - then sharpened with your team's tacit knowledge, expertise, and judgment.
(02)
Specialist AI workers bring clarity to complex processes by selecting relevant evidence, testing assumptions, identifying gaps, and structuring conclusions - with your team following the logic, encoding new strategies, and providing guidance.
(03)
Your team approves and carries conclusions forward, confident every call is data-backed and grounded in the full picture - while the platform ensures insights compound and decisions stay transparent and traceable.
Team
Our team has spent years building and deploying production AI systems in some of the world's most complex and sensitive enterprise environments. We have seen where AI succeeds, where it breaks, and what it takes for serious organizations to trust it.
Now we are applying that experience to drug development.

Founders